APA

Finan C., Gaulton A., Kruger F. A., Lumbers R. T., Shah T., Engmann J., Galver L., Kelley R., Karlsson A., Santos R., Overington J. P., Hingorani A. D. & Casas J. P. (20171218). The druggable genome and support for target identification and validation in drug development. : Science translational medicine.

Chicago

Finan Chris, Gaulton Anna, Kruger Felix A, Lumbers R Thomas, Shah Tina, Engmann Jorgen, Galver Luana, Kelley Ryan, Karlsson Anneli, Santos Rita, Overington John P, Hingorani Aroon D and Casas Juan P. 20171218. The druggable genome and support for target identification and validation in drug development. : Science translational medicine.

Harvard

Finan C., Gaulton A., Kruger F. A., Lumbers R. T., Shah T., Engmann J., Galver L., Kelley R., Karlsson A., Santos R., Overington J. P., Hingorani A. D. and Casas J. P. (20171218). The druggable genome and support for target identification and validation in drug development. : Science translational medicine.

MLA

Finan Chris, Gaulton Anna, Kruger Felix A, Lumbers R Thomas, Shah Tina, Engmann Jorgen, Galver Luana, Kelley Ryan, Karlsson Anneli, Santos Rita, Overington John P, Hingorani Aroon D and Casas Juan P. The druggable genome and support for target identification and validation in drug development. : Science translational medicine. 20171218.